USD
+$0.00
(+0.00%
)At Close (As of Sep 16, 2025)
$40.81M
Market Cap
-
P/E Ratio
-1.1
EPS
$2.52
52 Week High
$0.24
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $10M |
Total Revenue | $11M |
Cost Of Revenue | $925K |
Costof Goods And Services Sold | $925K |
Operating Income | -$74M |
Selling General And Administrative | $22M |
Research And Development | $63M |
Operating Expenses | $84M |
Investment Income Net | - |
Net Interest Income | $3.4M |
Interest Income | $3.4M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $925K |
Income Before Tax | -$70M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$70M |
Comprehensive Income Net Of Tax | - |
Ebit | -$74M |
Ebitda | -$73M |
Net Income | -$70M |
Field | Value (USD) |
---|---|
Total Assets | $52M |
Total Current Assets | $51M |
Cash And Cash Equivalents At Carrying Value | $49M |
Cash And Short Term Investments | $49M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $1.2M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $2.2M |
Other Non Current Assets | - |
Total Liabilities | $38M |
Total Current Liabilities | $15M |
Current Accounts Payable | $1.9M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $836K |
Total Non Current Liabilities | $24M |
Capital Lease Obligations | $836K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $836K |
Other Current Liabilities | $12M |
Other Non Current Liabilities | $20M |
Total Shareholder Equity | $14M |
Treasury Stock | - |
Retained Earnings | -$486M |
Common Stock | $6K |
Common Stock Shares Outstanding | $49M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$72M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $925K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $9.5M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $342K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$70M |
Field | Value (USD) |
---|---|
Gross Profit | $10M |
Total Revenue | $11M |
Cost Of Revenue | $925K |
Costof Goods And Services Sold | $925K |
Operating Income | -$74M |
Selling General And Administrative | $22M |
Research And Development | $63M |
Operating Expenses | $84M |
Investment Income Net | - |
Net Interest Income | $3.4M |
Interest Income | $3.4M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $925K |
Income Before Tax | -$70M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$70M |
Comprehensive Income Net Of Tax | - |
Ebit | -$74M |
Ebitda | -$73M |
Net Income | -$70M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers. The company is headquartered in San Diego, California.